The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you.
February 28, 2019
With a new Parkinson's drug for "off" time on the market and another under FDA review, you may wonder if one of these as-needed treatments is right for you.
February 27, 2019
Listen to our expert panelists talk about medical devices that can manage certain Parkinson's symptoms.
February 25, 2019
Our latest round of grants includes projects across our roadmap strategy to define, measure and treat Parkinson's disease.
February 20, 2019
The Michael J. Fox Foundation and The Silverstein Foundation for Parkinson's with GBA are funding studies into the most common Parkinson's genetic risk factor.
February 19, 2019
MJFF spoke with Joohi Jimenez-Shahed, MD, principal investigator of the DBS registry, to understand the goals of the study.
February 15, 2019
Runners, walkers, cyclists and supporters are encouraged to join MJFF-hosted Fox Trot 5K Run/Walk and Tour de Fox Cycling Series in 2019.
February 14, 2019
MJFF partners in the Australian Parkinson's Mission to support clinical trials of repurposed therapies that could slow the progression of the disease.
February 13, 2019
Listen to Dr. Rachel Dolhun tackle widespread myths about levodopa.
February 07, 2019
Levodopa is the most effective Parkinson's medication, but there are many misconceptions about what this drug can and can't do. In this video, Dr. Dolhun discusses the facts about levodopa.
February 06, 2019
The agency began reviewing paraquat in 2017 and has until October 2022 to make a decision on its future use.